HOME >> BIOLOGY >> NEWS
DNA test solving Chesapeake's toxic mysteries

As the summer heats up Chesapeake Bay waters, a new kind of test to detect toxic marine microbes is sharpening Maryland efforts to predict fish-killing Pfiesteria. The test also helps medical studies of illness associated with the microbe.

David Oldach of the University of Maryland Biotechnology Institute (UMBI) reports that the test, applied to samples of mud or water, rapidly identifies Pfiesteria piscicida. In 1997, the microbe was linked with major fish kills in three Maryland rivers as well as previous fish kills in North Carolina. In addition, watermen near the fish kills and laboratory workers handling Pfiesteria cultures have suffered from illness ranging from skin lesions and stomach cramps to temporary memory loss and learning impairment lasting up to seven weeks.

In a recent issue of the Proceedings of the National Academy of Sciences, Oldach writes that the test is based on a "time-tested molecular biology method used commonly in medical research." The method, called HMA, is more often used to tease ut different strains of viruses in studies of Hepatitis C, AIDS, or gene mutations linked with cancer, or genetic diseases, such as cystic fibrosis.

Oldach and colleagues at UMBI's Institute of Human Virology (IHV) applied the method to samples of water and cultures of Pfiesteria-like microbes from Maine, Maryland, and North Carolina. The result is a DNA fingerprint of Pfiesteria used in the new test. The test can be adapted to detect other toxic marine organisms, he adds.

Last year in Maryland, experiments on the new test helped show that P. piscicida existed in at least 14 rivers and increased dramatically in July and August, according to Dave Goshorn, chief of the Maryland Department of Natural Resources' (DNR) Living Resource Assessment Program. "We found that the new test works so well, we will expand from 50 to 100 testing sites in the Bay area in 2000, in addition to any fish kill sites."

The new Pfiesteria test i
'"/>

Contact: Steve Berberich
berberic@umbi.umd.edu
410-385-6315
University of Maryland Biotechnology Institute
30-Jul-2000


Page: 1 2 3

Related biology news :

1. Carnegie Mellon scientists reveal ways of studying, resolving PCB contamination in US rivers
2. Imaging the brain solving problems through insight
3. Saint Louis University researchers make breakthrough towards solving the cause of cancer development
4. Chemistry to play major role in solving 21st century challenges
5. Resolving Conflicts -- What We Can Learn From The Apes
6. Rice finds on-off switch for buckyball toxicity
7. Prion propagation: Avoiding the toxic oligomer
8. Byproduct of water-disinfection process found to be highly toxic
9. Stem cells more vulnerable to toxic chemotherapy when protective molecule is disabled
10. Sediments in many Central Valley streams contain toxic levels of pyrethroid pesticides
11. JGI decodes wood & toxic waste-degrading fungus genome

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/16/2016)... 16, 2016 Research and Markets has announced ... Global Forecast to 2021" report to their offering. ... The biometric vehicle access ... a CAGR of 14.06% from 2016 to 2021. The market is ... to reach 854.8 Million by 2021. The growth of the biometric ...
(Date:12/15/2016)... , Dec. 15, 2016   WaferGen Bio-systems, ... held genomics technology company, announced today that on December ... Qualifications Department of The Nasdaq Stock Market LLC which ... bid price of WaferGen,s common stock had been at ... WaferGen has regained compliance with Listing Rule 5550(a)(2) of ...
(Date:12/15/2016)...  There is much more to innovative access systems ... Continental will demonstrate the intelligence of today,s solutions at ... Through the combination of the keyless entry and start ... the international technology company is opening up new possibilities ... "The integration of biometric elements brings our expertise ...
Breaking Biology News(10 mins):
(Date:1/19/2017)... and GAITHERSBURG, Md. ... MKT: PIP) and Altimmune, Inc., a privately-held immunotherapeutics ... of a definitive agreement for the merger of ... current investors include Novartis Venture Fund, HealthCap, Truffle ... be a fully-integrated and diversified immunotherapeutics company with ...
(Date:1/19/2017)... AquaBounty Technologies, Inc. (AIM: ABTU; NASDAQ: AQB), ... and a majority-owned subsidiary of Intrexon Corporation (NYSE: ... listing of its common shares on the NASDAQ Stock ... "AquaBounty,s listing on NASDAQ represents an important milestone ... the U.S. markets as we advance plans for commercial ...
(Date:1/19/2017)... Ca (PRWEB) , ... January 18, 2017 , ... ... events for tech innovators, engineers, and scientists from around the world, was today ... News. The awards program is based entirely on merit and decided upon by ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... services spanning the full spectrum of drug and device development, and Prism ... pharma/device companies and clinicians, today announced Verified Clinical Trials (VCT) has ...
Breaking Biology Technology:
Cached News: